FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

34793111000001102: Xarelto 15mg/20mg treatment initiation pack (Bayer Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Nov 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2255551000001116 Xarelto 15mg/20mg treatment initiation pack (Bayer Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2255561000001118 Xarelto 15mg/20mg treatment initiation pack (Bayer Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xarelto 15mg/20mg treatment initiation pack (Bayer Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Xarelto 15mg/20mg treatment initiation pack (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Xarelto 15mg/20mg treatment initiation pack (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Xarelto 15mg/20mg treatment initiation pack (Bayer Plc) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring false Inferred relationship Existential restriction modifier
Xarelto 15mg/20mg treatment initiation pack (Bayer Plc) Is a Rivaroxaban 15mg tablets and Rivaroxaban 20mg tablets true Inferred relationship Existential restriction modifier
Xarelto 15mg/20mg treatment initiation pack (Bayer Plc) Has active ingredient Rivaroxaban true Inferred relationship Existential restriction modifier
Xarelto 15mg/20mg treatment initiation pack (Bayer Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Xarelto 15mg/20mg treatment initiation pack (Bayer Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Xarelto 15mg/20mg treatment initiation pack (Bayer Plc) Has dispensed dose form Dose form not applicable (qualifier value) true Inferred relationship Existential restriction modifier
Xarelto 15mg/20mg treatment initiation pack (Bayer Plc) Has excipient Lactose false Inferred relationship Existential restriction modifier
Xarelto 15mg/20mg treatment initiation pack (Bayer Plc) Is a Xarelto true Inferred relationship Existential restriction modifier
Xarelto 15mg/20mg treatment initiation pack (Bayer Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Xarelto 15mg/20mg treatment initiation pack (Bayer Plc) 49 tablet 1 x (42 tablets + 7 tablets) Has AMP True Xarelto 15mg/20mg treatment initiation pack (Bayer Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start